These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1971652)

  • 1. The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly.
    Vozza A; Zerman AM; Bertoni L; Cattini GC; Tosto L; Greco N; Romano F; Panebianco R; Benedetti M
    J Hosp Infect; 1990 Apr; 15 Suppl A():87-9. PubMed ID: 1971652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ceftazidime in common infections in childhood. Experience in 262 cases].
    Fanos V; Fostini R; Panebianco R; Danieli D
    Clin Ter; 1991 Jun; 137(5):327-32. PubMed ID: 1832605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
    Mouton YJ; Beuscart C
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():145-56. PubMed ID: 8543490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group.
    Romanelli G; Cravarezza P
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():109-19. PubMed ID: 8543487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of ceftazidime in intractable respiratory tract infections].
    Takenaka S; Fukuda K; Kimura T; Shima K; Ushijima M; Egashira Y; Ikeda S; Hiraoka T; Higuchi S; Fujise T
    Jpn J Antibiot; 1989 Dec; 42(12):2555-65. PubMed ID: 2693754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
    Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH
    Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
    Naide Y; Aso Y; Oshi M; Kumamoto Y; Hirose T; Machida T; Tsuchida S; Suzuki K; Orikasa S; Kawada Y
    Hinyokika Kiyo; 1991 Apr; 37(4):447-64. PubMed ID: 1892004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
    Huston MJ; Lentino JR
    Clin Ther; 1992; 14(4):595-602. PubMed ID: 1525793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ceftazidime in severe Gram-negative infections--a preliminary study.
    Clumeck N; Vanlaethem Y; Gordts B; Jaspar N; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():317-21. PubMed ID: 19803007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime: therapeutic results in various infections.
    Sakellariou G; Alexopoulos E; Natshe T; Hadjidimitriou C; Kalpakoglou S; Karayiannis A; Papadimitriou M
    Chemioterapia; 1987 Jun; 6(2 Suppl):373-4. PubMed ID: 3334579
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience in the treatment of lower respiratory tract infections with ceftazidime.
    Pettersson T; Ahvonen P; Storgårds E
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():303-5. PubMed ID: 19803003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of ceftazidime in internal medicine in Japan.
    Shimada K
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():395-7. PubMed ID: 6225765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections.
    Chaudhary M; Shrivastava SM; Sehgal R
    Curr Clin Pharmacol; 2009 Jan; 4(1):62-6. PubMed ID: 19149503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B; Berman SJ; Geckler RW; Farkas SA
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of ceftazidime in infectious pathology].
    La Rosa F
    Minerva Med; 1985 Sep; 76(37):1657-62. PubMed ID: 3900812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study on ceftazidime in the treatment of intractable respiratory infections].
    Miyatake H; Takagi K; Yamaki K; Gonda H; Watanabe H; Satake T; Suzuki R; Mizuno K; Aihara H; Hara M
    Jpn J Antibiot; 1990 Jun; 43(6):1164-73. PubMed ID: 2232147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Multicenter comparative study of meropenem, a new carbapenemic preparation, administered intramuscularly. Treatment of respiratory and urinary infections in hospitalized patients]l].
    Lechi A; Montesi G
    Clin Ter; 1995 Jan; 146(1):31-47. PubMed ID: 7705012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime in the treatment of complicated respiratory and urinary tract infections.
    Loebis LH; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():59-64. PubMed ID: 6352656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.